相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
Michael Dussiot et al.
NATURE MEDICINE (2014)
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
Rajasekhar N. V. S. Suragani et al.
NATURE MEDICINE (2014)
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Paul J. Schmidt et al.
BLOOD (2013)
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT
P. Armand et al.
BONE MARROW TRANSPLANTATION (2013)
The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice
Guillem Casanovas et al.
HAEMATOLOGICA (2013)
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1
Ilaria Ambaglio et al.
HAEMATOLOGICA (2013)
Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload
Haruhiko Ohashi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Shuling Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes
Julia Hartmann et al.
LEUKEMIA RESEARCH (2013)
A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes
Jaroslav Cermak et al.
LEUKEMIA RESEARCH (2013)
Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients
Rodolfo Cancado et al.
ACTA HAEMATOLOGICA (2012)
SF3B1 and the riddle of the ring sideroblast
Norbert Gattermann
BLOOD (2012)
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
Valeria Visconte et al.
BLOOD (2012)
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Antonella Nai et al.
BLOOD (2012)
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
Norbert Gattermann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The effect of iron overload and chelation on erythroid differentiation
Kazuki Taoka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome
Shohei Kikuchi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
Qingdu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome
Alan F. List et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Selective toxicity towards myelodysplastic hematopoietic progenitors - Another rationale for iron chelation in MDS
E. Fibach et al.
LEUKEMIA RESEARCH (2012)
Hepcidin and Disorders of Iron Metabolism
Tomas Ganz et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati et al.
BLOOD (2011)
Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome
Hussam Ghoti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
Noemi B. A. Roy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase
Li Zhou et al.
CANCER RESEARCH (2011)
Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes Recent Developments
Heather A. Leitch
DRUGS (2011)
EFFICACY AND SAFETY OF ADMINISTRATION OF ORAL IRON CHELATOR DEFERIPRONE IN PATIENTS WITH EARLY MYELODYSPLASTIC SYNDROME
Jaroslav Cermak et al.
HEMOGLOBIN (2011)
Iron-Chelating Therapy for Transfusional Iron Overload
Gary M. Brittenham
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
Valeria Santini et al.
PLOS ONE (2011)
The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate
David P. Steensma
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2011)
Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies
Emanuele Angelucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Deferiprone-associated myelotoxicity
F. N. Al-Refaie et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Maria Domenica Cappellini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
Hussam Ghoti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Sara Gardenghi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
Celine Callens et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
Christian Rose et al.
LEUKEMIA RESEARCH (2010)
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Norbert Gattermann et al.
LEUKEMIA RESEARCH (2010)
Transferrin therapy ameliorates disease in β-thalassemic mice
Huihui Li et al.
NATURE MEDICINE (2010)
Iron chelation therapy associated with improvement of hematopoiesis in transfusion-dependent patients
Esther Natalie Oliva et al.
TRANSFUSION (2010)
Early Deferasirox Treatment in a Patient with Myelodysplastic Syndrome Results in a Long-Term Reduction in Transfusion Requirements
Silvana Capalbo et al.
ACTA HAEMATOLOGICA (2009)
High nontransferrin bound iron levels and heart disease in thalassemia major
Antonio Piga et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Deferasirox removes cardiac iron and attenuates oxidative stress in the iron-overloaded gerbil
Rabaa M. Al-Rousan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Deferasirox in MDS patients with transfusion-caused iron overload-a phase-II study
Georgia Metzgeroth et al.
ANNALS OF HEMATOLOGY (2009)
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Esther Zipperer et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Iron Overload: Consequences, Assessment, and Monitoring
Ali T. Taher et al.
HEMOGLOBIN (2009)
Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
Bozena Novotna et al.
LEUKEMIA RESEARCH (2009)
Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis
E. Messa et al.
ACTA HAEMATOLOGICA (2008)
Consensus statement on iron overload in myelodysplastic syndromes
John M. Bennett
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts
Cheng E. Chee et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression
Constance Delaby et al.
BIOCHEMICAL JOURNAL (2008)
Inhibition of the TGF-β receptor I kinase promotes hematopoiesis in MDS
Li Zhou et al.
BLOOD (2008)
Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes
Janice Gabrilove et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias
Anna Angela Di Tucci et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Intracellular labile iron
William Breuer et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
Norbert Gattermann
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts
Zachary P. Nearman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2*technique
Eli Konen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Myocardial iron loading by magnetic resonance imaging T2*in good prognostic myelodysplastic syndrome patients on long-term blood transfusions
Joseph Chacko et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload
Clara Camaschella et al.
BLOOD (2007)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality
Masaaki Takatoku et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Ineffective erythropoiesis in β-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin
Sara Gardenghi et al.
BLOOD (2007)
Urinary hepcidin in congenital chronic anemias
Susan L. Kearney et al.
PEDIATRIC BLOOD & CANCER (2007)
Suppression of hepcidin during anemia requires erythropoietic activity
Mihwa Pak et al.
BLOOD (2006)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome
EN Oliva et al.
LEUKEMIA RESEARCH (2005)
Medical progress:: β-thalassemia
D Rund et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
LPI-labile plasma iron in iron overload
ZI Cabantchik et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Management of anemia associated with myelodysplastic syndrome
E Hellström-Lindberg
SEMINARS IN HEMATOLOGY (2005)
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded β-thalassemia/HbE patients treated with an oral chelator
P Pootrakul et al.
BLOOD (2004)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Labile plasma iron in iron overload: redox activity and susceptibility to chelation
BP Esposito et al.
BLOOD (2003)
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life
E Hellström-Lindberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias
PD Jensen et al.
BLOOD (2003)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson et al.
EUROPEAN HEART JOURNAL (2001)
Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb BAC carrying the human β-globin locus
Y Huang et al.
BLOOD CELLS MOLECULES AND DISEASES (2000)
A novel mammalian iron-regulated protein involved in intracellular iron metabolism
S Abboud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register
B Modell et al.
LANCET (2000)
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
AT McKie et al.
MOLECULAR CELL (2000)
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major
PT Telfer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
